Salters T, Sharpe B, Raychoudhury S, Nagdas S
Int J Biochem Physiol. 2024; 8(2).
PMID: 39145117
PMC: 11323058.
DOI: 10.23880/ijbp-16000237.
Nagdas S, Britney T, Simpson D, Salters T, Raychoudhury S
Int J Biochem Physiol. 2024; 8(2).
PMID: 39135670
PMC: 11318641.
DOI: 10.23880/ijbp-16000228.
Chen J, Wu L, Li Y
Biomark Res. 2024; 12(1):53.
PMID: 38816776
PMC: 11141035.
DOI: 10.1186/s40364-024-00601-0.
Nagdas S, Wallace S, Eaford D, Baker R, Carr K, Raychoudhuri S
Mol Reprod Dev. 2020; 87(12):1206-1218.
PMID: 33216420
PMC: 7775341.
DOI: 10.1002/mrd.23438.
Bao Z, Li J, Zhang P, Pan Q, Liu B, Zhu J
Ann Transplant. 2020; 25:e921287.
PMID: 32366814
PMC: 7219555.
DOI: 10.12659/AOT.921287.
Overexpression of fibrinogen-like protein 2 protects against T cell-induced colitis.
Bartczak A, Zhang J, Adeyi O, Amir A, Grant D, Gorczynski R
World J Gastroenterol. 2017; 23(15):2673-2684.
PMID: 28487604
PMC: 5403746.
DOI: 10.3748/wjg.v23.i15.2673.
Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation.
Liu X, Liu Y, Chen F
Oncotarget. 2016; 8(2):3711-3723.
PMID: 27732962
PMC: 5356913.
DOI: 10.18632/oncotarget.12533.
The reduced soluble fibrinogen-like protein 2 and regulatory T cells in acute coronary syndrome.
Liu K, Li T, Huang S, Long R, You Y, Liu J
Exp Biol Med (Maywood). 2015; 241(4):421-5.
PMID: 26515143
PMC: 4935412.
DOI: 10.1177/1535370215612138.
Physiological functions and clinical implications of fibrinogen-like 2: A review.
Yang G, Hooper W
World J Clin Infect Dis. 2015; 3(3):37-46.
PMID: 26161303
PMC: 4495006.
DOI: 10.5495/wjcid.v3.i3.37.
The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.
Hu J, Yan J, Rao G, Latha K, Overwijk W, Heimberger A
Int Rev Immunol. 2014; 35(4):325-339.
PMID: 25259408
PMC: 5257246.
DOI: 10.3109/08830185.2014.956360.
The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.
Urbanellis P, Shyu W, Khattar R, Wang J, Zakharova A, He W
Immunology. 2014; 144(1):91-106.
PMID: 24990517
PMC: 4264913.
DOI: 10.1111/imm.12354.
Intestinal and peripheral fibrinogen-like protein 2 expression in inflammatory bowel disease.
Dong X, Ye X, Chen X, Chen T, Xie S, Li Q
Dig Dis Sci. 2013; 59(4):769-77.
PMID: 24287641
PMC: 7087870.
DOI: 10.1007/s10620-013-2962-9.
The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection.
Shalev I, Selzner N, Helmy A, Foerster K, Adeyi O, Grant D
Rambam Maimonides Med J. 2013; 1(1):e0004.
PMID: 23908776
PMC: 3721661.
DOI: 10.5041/RMMJ.10004.
Correlating structure and function during the evolution of fibrinogen-related domains.
Doolittle R, McNamara K, Lin K
Protein Sci. 2012; 21(12):1808-23.
PMID: 23076991
PMC: 3575912.
DOI: 10.1002/pro.2177.
Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosis.
Yanaba K, Asano Y, Noda S, Akamata K, Aozasa N, Taniguchi T
Clin Rheumatol. 2012; 32(1):43-7.
PMID: 22983266
DOI: 10.1007/s10067-012-2089-y.
Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2.
Hancock W, Szaba F, Berggren K, Parent M, Mullarky I, Pearl J
Proc Natl Acad Sci U S A. 2004; 101(9):3005-10.
PMID: 14976252
PMC: 365735.
DOI: 10.1073/pnas.0308369101.
The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.
Marsden P, Ning Q, Fung L, Luo X, Chen Y, Mendicino M
J Clin Invest. 2003; 112(1):58-66.
PMID: 12840059
PMC: 162293.
DOI: 10.1172/JCI18114.
Identification of genes associated with the progression of adult T cell leukemia (ATL).
Kohno T, Moriuchi R, Katamine S, Yamada Y, Tomonaga M, Matsuyama T
Jpn J Cancer Res. 2000; 91(11):1103-10.
PMID: 11092974
PMC: 5926287.
DOI: 10.1111/j.1349-7006.2000.tb00892.x.
Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis.
Levy G, Liu M, Ding J, Yuwaraj S, Leibowitz J, Marsden P
Am J Pathol. 2000; 156(4):1217-25.
PMID: 10751347
PMC: 1876871.
DOI: 10.1016/S0002-9440(10)64992-9.
Crystal structure of a recombinant alphaEC domain from human fibrinogen-420.
Spraggon G, Applegate D, Everse S, Zhang J, Veerapandian L, Redman C
Proc Natl Acad Sci U S A. 1998; 95(16):9099-104.
PMID: 9689040
PMC: 21298.
DOI: 10.1073/pnas.95.16.9099.